Related Experiment Video
Updated: May 28, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
[Dementia - a relevant subject in psychiatric research?]
1Klinische Abteilung für Sozialpsychiatrie, Medizinische Universität Wien, Wien. johannes.wancata@meduniwien.ac.at
Psychiatrische Praxis
|October 5, 2011
Summary
Dementia research is a significant focus in psychiatric journals, with 18.2% of papers dedicated to dementia and cognition. However, health service research in this area remains notably absent.
Area of Science:
- Psychiatry
- Neuroscience
- Public Health
Background:
- Global demographic shifts necessitate intensified research into dementia and cognitive disorders.
- Psychiatric literature serves as a crucial indicator of research trends and priorities.
Purpose of the Study:
- To systematically analyze the prevalence of dementia-related research within a prominent German-speaking psychiatric journal.
- To identify research gaps, particularly in health services research concerning dementia.
Main Methods:
- A comprehensive systematic analysis was conducted on all papers published in a selected German-speaking psychiatric journal.
- Content analysis focused on identifying publications related to dementia and cognitive impairment.
Main Results:
- Approximately 18.2% of all published articles were identified as pertaining to dementia and cognition.
- Dementia and cognition research is a major topic, surpassed only by studies on schizophrenia.
Conclusions:
- Dementia is a significant area of focus within psychiatric research.
- There is a substantial lack of health services research related to dementia, indicating a critical gap.
- Future research efforts should address the identified deficit in health services research for dementia.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...